Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. - Wikidata - wikimedia - TriplyDB

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

http://www.wikidata.org/entity/Q30884055

about

Unmet Needs in LDL-C Lowering: When Statins Won't Do!Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease Statin use in prediabetic patients: rationale and results to date Profile of evolocumab and its potential in the treatment of hyperlipidemia Current and Emerging Uses of Statins in Clinical Therapeutics: A Review PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter Hypertriglyceridemia: the importance of identifying patients at risk.LDL-Cholesterol: Standards of Treatment 2016: A German Perspective.Pitavastatin and carbohydrate metabolism: what is the evidence?Cardiovascular Disease in Women: Clinical Perspectives.Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.Statins in Primary Prevention: Uncertainties and Gaps in Randomized Trial Data.A Case of Statin-Associated Autoimmune Myopathy Role of Intestinal LXRα in Regulating Post-prandial Lipid Excursion and Diet-Induced Hypercholesterolemia and Hepatic Lipid Accumulation.Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.Genetics of cardiovascular disease: Importance of sex and ethnicity.Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients.Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study.Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases Treatment Options for Statin-Associated Muscle Symptoms.Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Its Inhibitors: a Review of Physiology, Biology, and Clinical Data.Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study.Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL/6J mice.Statins Impede a Healthy Lifestyle Triglyceride and cardiovascular risk: A critical appraisal.Cholesterol trials and mortality.Statin use and all-cancer survival: prospective results from the Women's Health Initiative.Lupin Peptides Modulate the Protein-Protein Interaction of PCSK9 with the Low Density Lipoprotein Receptor in HepG2 Cells.Safety of atorvastatin in Asian patients within clinical trials.PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.

P2860

Q26741705-2F508D6B-5A10-4E7D-A56B-2EDB9B39C74B Q26745946-FF3F88DE-71B5-49D2-A961-D04D541556F5 Q26786008-ED525E86-8128-4DBF-BF7E-DED7230A3C87 Q27004235-1BA90D2E-46B8-49F3-9C19-CD8DF084C399 Q28076346-72C2D1A1-6380-48C6-8D6E-D18301D53899 Q28275648-9AD443C0-B109-4881-804E-2FAB665E1076 Q28831365-83148F9C-6195-41E2-BF41-8D4DE45A3256 Q30244825-307676DE-29EA-440D-A0F5-353298D164B5 Q30248925-50F30214-FAD2-4DF0-BDBE-2FC0912081FC Q30251801-1146C682-6094-43CC-9AFE-18596D73E5A9 Q30743765-3067226E-C74F-49EA-9C84-D84F16111566 Q31105715-1B9A18CE-F304-49C1-B2B2-3B1DB83F6224 Q31133434-48410386-FCFB-4C48-B1DC-B1C950080F24 Q33584194-8A8A1A87-FE54-4FDC-A400-43F112AD52CB Q33650363-B9D4A74C-3B67-4B5F-81D9-C6507BCA6D65 Q33814374-100D63B6-753D-4A1D-82C7-6AB3903D7886 Q33830394-3DC4B60C-86AF-476A-929F-352EB7694FA6 Q35738812-9C710776-5C8E-402C-A61F-D576249A9803 Q35886333-FBFE4244-2E67-4239-B75B-A391A61CE0AE Q36082805-0B007B36-8D0D-4602-820C-C080AAD0764E Q36260050-B882095B-49D7-400E-ADEF-25DA2ADD3D3B Q36265758-0783C583-845A-445C-9C5F-116FA3EBC760 Q36294394-41D3E028-19D3-42E1-9C30-F88BE1C6F1C6 Q36411986-139F50E4-79ED-40BC-81F7-53B52B6A105E Q36479927-8D477951-80EB-4387-B9CC-F8C021F324B9 Q36543436-DAF04E6F-289A-4522-AFA4-F004BA2656F0 Q36923769-C93037B7-928A-436C-86EC-DC6A3F807B33 Q36996761-1B501BB4-575E-4E76-B891-45E30E72FAD8 Q37015549-A34F4F32-A1F0-4CC1-925E-EDE0BA3EB488 Q37030666-D87F4BB7-D5D9-418C-9DCE-AAED6487486C Q37061345-AB09D72D-53E8-4DE2-818A-9F70A6401971 Q37101312-679E5F2E-6E1C-41A0-8615-3924C5A969B1 Q37456623-E919775A-A10A-44CE-AAAF-F657FAEB6B1E Q37549374-C6DE9975-282A-4038-82E9-425E46EA1958 Q37685518-7B28CAFC-2097-467E-A4E8-11D3C1936B4B Q37695071-BAF30FF5-D6E3-4237-836C-8B0D8160E99A Q37703258-8AAAD6E4-9844-48FD-96F8-AB062586B9D6 Q37744428-26AB4E2C-596E-40CA-88DE-4FC030BA10C3 Q38374348-B334F8C3-FD30-4ABA-9C78-6A5149838B35 Q38380488-8A771EBC-D0D8-4F7B-B069-F2A766DD14B8

P2860

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

http://www.wikidata.org/entity/Q30884055

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Efficacy and safety of LDL-low ...... pants in 27 randomised trials.

@ast

Efficacy and safety of LDL-low ...... pants in 27 randomised trials.

@en

type

label

Efficacy and safety of LDL-low ...... pants in 27 randomised trials.

@ast

Efficacy and safety of LDL-low ...... pants in 27 randomised trials.

@en

prefLabel

Efficacy and safety of LDL-low ...... pants in 27 randomised trials.

@ast

Efficacy and safety of LDL-low ...... pants in 27 randomised trials.

@en

P1433

Q30884055-4E8BBB7F-D7E7-4B4A-8AA9-7F87AC384849

P1476

Q30884055-2AB573FE-DF78-4036-9F91-36D9EE9E9CB0

P2093

Q30884055-1F740078-CDAF-433D-8CBA-F8920EDB6D5D

Q30884055-41639402-05E6-483F-B692-F7AD09619A8E

Q30884055-43286F08-7F32-4BE2-A53F-7FD0FFB8B5A4

Q30884055-4AB2817E-61FA-4090-B209-DF8CEA6149C7

Q30884055-783AD2F4-5E37-4368-8241-5326FAA7183E

Q30884055-7E1188FF-E50B-4C89-94E9-C3DB164534C7

Q30884055-8E72E962-9A35-49C2-A72F-CD11846F45AC

Q30884055-920BEE6F-4CCC-4CED-AB62-C5C9884EFD1E

Q30884055-995AF816-8300-4B73-AD71-6F918F8599BA

Q30884055-A532A5B0-8A70-46CB-AE93-EC8ED289CCD1

P304

Q30884055-4873B7F4-3687-4211-AE80-9C92B9F16495

P31

Q30884055-AEB2B447-C7A5-4842-A5A5-931E8B8D00D7

Q30884055-C0CE5D00-3C6E-4A6B-8668-68131D9E4301

P356

Q30884055-8BCFCE08-63CB-494F-8157-58313F389D03

P407

Q30884055-5B3B4BED-EAB4-462E-BD55-4ADA7FCEF5D5

P433

Q30884055-441A6E47-487D-4ACD-91ED-A8E6E40C5754

P478

Q30884055-BFF460DC-09F5-49D3-9037-2340EB5D5254

P50

Q30884055-097D2E43-DA89-40F9-B263-0EA46DE9CA98

Q30884055-1EF5E42F-0894-494C-B841-2EE6A41E372D

Q30884055-2BC7E975-D486-4013-8D0B-6ED8C7F0966D

Q30884055-57F9CA75-47C4-40DE-BD51-99116A7AB67D

Q30884055-D2E8B244-7453-468C-B8D0-E4EA533E1E9D

Q30884055-F05C139C-A8B2-4692-8F88-5974F96D9118

P577

Q30884055-C440BDC2-6D1B-401D-B9D7-C1E9950C0AF4

P698

Q30884055-53BA93EB-8A87-4F41-A111-692DEE54BAF6

P356

S0140-6736(14)61368-4

P1433

P1476

Efficacy and safety of LDL-low ...... pants in 27 randomised trials.

@en

P2093

Adrienne Kirby

http://www.w3.org/2001/XMLSchema#string

Anthony Keech

http://www.w3.org/2001/XMLSchema#string

Barry Davis

http://www.w3.org/2001/XMLSchema#string

Cholesterol Treatment Trialists' (CTT) Collaboration

http://www.w3.org/2001/XMLSchema#string

Colin Baigent

http://www.w3.org/2001/XMLSchema#string

John La Rosa

http://www.w3.org/2001/XMLSchema#string

John Simes

http://www.w3.org/2001/XMLSchema#string

Jordan Fulcher

http://www.w3.org/2001/XMLSchema#string

Lisa Blackwell

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Franzosi

http://www.w3.org/2001/XMLSchema#string

P304

1397-1405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(14)61368-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

9976

http://www.w3.org/2001/XMLSchema#string

P478

385

http://www.w3.org/2001/XMLSchema#string

P50

Eugene Braunwald

Jonathan Emberson

Helen M. Colhoun

P577

2015-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25579834

http://www.w3.org/2001/XMLSchema#string